ImageneBio

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ImageneBio and other ETFs, options, and stocks.

About IMA

ImageneBio, Inc. is a clinical-stage biotechnology company that boldly imagines a world where patients can be free from the burden of grievous immunological/autoimmune and inflammatory (I&I) diseases. It focuses on the development of new medicines with differentiated profiles that can effectively control and change the course of I&I diseases for affected patients, treat their symptoms, and improve quality of life. 

CEO
Kristin Yarema
CEOKristin Yarema
Employees
15
Employees15
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2016
Founded2016
Employees
15
Employees15

IMA Key Statistics

Market cap
65.65M
Market cap65.65M
Price-Earnings ratio
-1.06
Price-Earnings ratio-1.06
Dividend yield
Dividend yield
Average volume
17.45K
Average volume17.45K
High today
$5.62
High today$5.62
Low today
$5.55
Low today$5.55
Open price
$5.61
Open price$5.61
Volume
7.23K
Volume7.23K
52 Week high
$18.00
52 Week high$18.00
52 Week low
$3.94
52 Week low$3.94

Stock Snapshot

With a market cap of 65.65M, ImageneBio(IMA) trades at $5.55. The stock has a price-to-earnings ratio of -1.06.

On 2026-06-09, ImageneBio(IMA) stock moved within a range of $5.55 to $5.62. With shares now at $5.55, the stock is trading 0.0% above its intraday low and -1.2% below the session's peak.

Trading activity shows a volume of 7.23K, compared to an average daily volume of 17.45K.

Over the past 52 weeks, ImageneBio(IMA) stock has traded between a high of $18.00 and a low of $3.94.

Over the past 52 weeks, ImageneBio(IMA) stock has traded between a high of $18.00 and a low of $3.94.

People also own

Based on the portfolios of people who own IMA. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.